C-Type Lectins and Immune Surveillance in ALD

C 型凝集素与 ALD 中的免疫监视

• 批准号: 10426861
• 负责人: Adam Kim
• 金额: $ 6.16万
• 依托单位: CLEVELAND CLINIC LERNER COM-CWRU
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-01 至 2022-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10426861
• 关键词: Administrative Supplement; C-Type Lectins; COVID-19 pandemic; Clinic; Clinical Immunology; Data; Enrollment; Goals; Immunologic Surveillance; Leadership; Learning; Mentors; Patients; Reagent; Research; Work; career; career development; experimental study; pandemic disease; skills

Project Summary This Administrative Supplement will provide an additional year of mentored research to compensate for research progress and career development that was delayed due to the COVID-19 pandemic. The pandemic forced research labs at the Cleveland Clinic to reduce to a quarter or half capacity for the last year, reduced the number of patients enrolled in studies, and decreased access to many critical lab supplies including reagents. As a result, research focus had to be shifted to remote work, and many year 1 and year 2 research and career goals for the K99 were unmet. During this extra year, the candidate will be able to finish experiments that were put off due to the pandemic and continue to develop skills in clinical immunology, generate the sequencing data outlined in the proposal, and learn leadership skills to transition into independence.

项目摘要 本行政副刊将额外提供一年的指导研究，以弥补 由于新冠肺炎疫情而推迟的研究进展和职业发展。大流行 去年，克利夫兰诊所的研究实验室被迫将产能减少到四分之一或一半，从而减少了 参加研究的患者数量增加，以及获得包括试剂在内的许多关键实验室用品的机会减少。 因此，研究重点不得不转移到远程工作，许多第一年和第二年的研究和职业生涯 K99的目标没有实现。在这额外的一年里，考生将能够完成之前 由于大流行而推迟，并继续发展临床免疫学技能，生成测序数据 并学习领导技能，以过渡到独立。